Instrument-based analysis of elemental impurities is a more specific way to test drugs for potentially toxic constituents. According to the requirements of drug regulatory authorities, the use of new, specific and sensitive measuring devices is essential. Drug manufacturers and raw material suppliers have been required to perform elemental impurities risk analysis and control (according to ICH Q3D "Guideline for elemental impurities") since June 2016 (Europe) and December 2017 (USA) when submitting new drug applications.
Specifically, this means that the analysis of heavy metal contamination has been changed from the previous non-specific method to a specific analysis of elemental impurities.
We offer complete development, validation and testing procedures with cGMP compliant documentation to prove all tests we perform. With our expert staff and superbly equipped, state-of-the-art laboratories, we can help you meet the requirements with ease.
Our experts have the technical expertise and regulatory qualifications required for method development, method validation, and routine testing. We have extensive experience with all methods included in the regulations and are ready to implement these new test methods.
Our highly qualified staff is always up to date with regard to the constantly changing requirements.
Our services also include customized processing of your samples to meet the requirements of pharmaceutical elemental analysis, based on a sound understanding of the ICH Q3D guideline.
Numerous validations and method implementations - tailored to the specific requirements resulting from matrix, dosage form and manufacturing characteristics, among others - have already been successfully carried out.
Want to learn how our experience with elemental impurities can help you meet regulatory requirements? Contact us today.
Tegeler Weg 33
D - 10589 Berlin
Kasteler Straße 45
D - 65203 Wiesbaden
Auf der Hüls 183
52068 Aachen
Schwanthaler Str. 111-115
80339 München
Tegeler Weg 33
10589 Berlin